References of 2,4,6-triiodo-5-[methyl-[3-oxo-3-[2,4,6-triiodo-N-methyl-3,5-bis(1,3,
4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]amino]-1-N,3-N-bis(1,
3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide
Title: Iotrolan
CAS Registry Number: 79770-24-4
CAS Name: 5,5¢-[(1,3-Dioxo-1,3-propanediyl)bis(methylimino)]bis[
N,N¢-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodo-1,3-benzenedicarboxamide]
Synonyms: 5,5¢-[malonylbis(methylimino)]bis[
N,N¢-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodoisophthalamide]; iotrol
Manufacturers' Codes: DL-3117; SH-437; ZK-39482
Trademarks: Isovist (Schering AG)
Molecular Formula: C37H48I6N6O18
Molecular Weight: 1626.23
Percent Composition: C 27.33%, H 2.98%, I 46.82%, N 5.17%, O 17.71%
Literature References: Nonionic, isotonic contrast medium. Prepn: M. Sovak, R. Ranganathan,
EP 33426;
eidem, US 4341756 (1981, 1982 both to Univ. Cal., Berkeley). Neurotoxicity study: M. Sovak
et al., Radiology 142, 115 (1982). Neuropharmacology: M. Sovak
et al., Am. J. Neuroradiol. 4, 319 (1983); and cerebral distribution: J.-C. Castel
et al., Neuroradiology 29, 206 (1987). Arthrographic evaluation in animals: J. Guerra
et al., Invest. Radiol. 19, 228 (1983). Cardiovascular effects in animals: P. Lanzer
et al., ibid. 20, 746 (1985). Clinical study of patient tolerance and diagnostic adequacy for intrathecal use: B. Hammer, E. Deisenhammer,
Neuroradiology 27, 337 (1985); B. Hoffmann
et al., ibid. 29, 380 (1987); M. D. Malnor
et al., Radiology 158, 845 (1986).
Properties: Colorless glassy solid. Soly at 20° (mgI/ml): water >400. LD50 in mice, rats (gI/kg): >26, 12.7 i.v. (Sovak, 1982).
Toxicity data: LD50 in mice, rats (gI/kg): >26, 12.7 i.v. (Sovak, 1982)
Therap-Cat: Diagnostic aid (radiopaque medium).
Keywords: Diagnostic Aid (Radiopaque Medium).